BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8943576)

  • 1. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling.
    Jurcevic S; Travers PJ; Hills A; Agrewala JN; Moreno C; Ivanyi J
    Int Immunol; 1996 Nov; 8(11):1807-14. PubMed ID: 8943576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis.
    Scholz E; Mestre-Ferrer A; Daura X; García-Medel N; Carrascal M; James EA; Kwok WW; Canals F; Álvarez I
    Arthritis Rheumatol; 2016 Oct; 68(10):2412-21. PubMed ID: 27158783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets.
    Kropshofer H; Bohlinger I; Max H; Kalbacher H
    Biochemistry; 1991 Sep; 30(38):9177-87. PubMed ID: 1892827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic and molecular studies of two kindreds expressing recombinant HLA DR1/DR2 haplotypes.
    Wisecarver J; Shepherd S; Beisel K; Rubocki R
    Tissue Antigens; 1993 Mar; 41(3):148-54. PubMed ID: 7686308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
    Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
    J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Murthy VL; Stern LJ
    Structure; 1997 Oct; 5(10):1385-96. PubMed ID: 9351812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
    Malcherek G; Gnau V; Jung G; Rammensee HG; Melms A
    J Exp Med; 1995 Feb; 181(2):527-36. PubMed ID: 7836909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody with specificity to the HLA-DR1 and -DR51 antigens.
    Loh MT; Chan SH; Ren EC
    Tissue Antigens; 1993 Aug; 42(2):100-4. PubMed ID: 8266318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins.
    Zavala-Ruiz Z; Strug I; Anderson MW; Gorski J; Stern LJ
    Chem Biol; 2004 Oct; 11(10):1395-402. PubMed ID: 15489166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
    Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
    BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of the P6/P7 region of the peptide-binding site of the human class II major histocompatability complex protein HLA-DR1.
    Zavala-Ruiz Z; Sundberg EJ; Stone JD; DeOliveira DB; Chan IC; Svendsen J; Mariuzza RA; Stern LJ
    J Biol Chem; 2003 Nov; 278(45):44904-12. PubMed ID: 12952957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited susceptibility to insulin-dependent diabetes is associated with HLA-DR1, while DR5 is protective.
    Maclaren N; Riley W; Skordis N; Atkinson M; Spillar R; Silverstein J; Klein R; Vadheim C; Rotter J
    Autoimmunity; 1988; 1(3):197-205. PubMed ID: 2979618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H; Max H; Halder T; Kalbus M; Muller CA; Kalbacher H
    J Immunol; 1993 Nov; 151(9):4732-42. PubMed ID: 8409432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.